Latest News
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
150 -
Did you enjoy reading this story? Click the heart to show your love.
90 -
Did you like reading this story? Click the heart to show your love.
66
Did you like reading this story? Click the heart to show your love.
1197
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.
More from Johnson & Johnson
November 18, 2021
The company now has more Lighthouse designations than any other—a marker of its excellence in manufacturing innovation. Learn how Johnson & Johnson sites are improving how and when we get the healthcare products and services we need and serving as a beacon to other manufacturers worldwide.
November 11, 2021
The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.
November 03, 2021
Learn about how one inspiring young man with the condition is thriving despite the challenges—and how Johnson & Johnson is helping him and others like him to find new ways to manage their mental illness.
